Remus Pharmaceuticals Limited (NSE:REMUS)

Remus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	8,870	7,320	13,192	10,163	-	-
Market Cap Growth	-20.92%	-44.51%	29.81%	-	-	-
Enterprise Value	9,204	7,581	13,164	10,212	-	-
Last Close Price	760.85	627.90	1118.05	860.48	-	-
PE Ratio	19.41	19.79	45.38	49.53	-	-
PS Ratio	1.03	0.85	2.13	4.77	-	-
PB Ratio	2.29	1.89	4.67	5.80	-	-
P/TBV Ratio	2.59	2.14	5.34	6.83	-	-
P/FCF Ratio	247.07	203.90	439.73	-	-	-
P/OCF Ratio	48.84	40.31	189.00	752.80	-	-
EV/Sales Ratio	1.07	0.88	2.12	4.80	-	-
EV/EBITDA Ratio	14.52	11.96	29.25	35.56	-	-
EV/EBIT Ratio	15.19	12.51	30.04	36.68	-	-
EV/FCF Ratio	256.38	211.16	438.80	-	-	-
Debt / Equity Ratio	0.07	0.07	0.08	0.08	0.42	0.03
Debt / EBITDA Ratio	0.43	0.43	0.50	0.49	0.71	0.04
Debt / FCF Ratio	7.54	7.54	7.66	-	3.08	0.04
Net Debt / Equity Ratio	-0.01	-0.01	-0.01	-0.06	0.26	-0.14
Net Debt / EBITDA Ratio	-0.05	-0.05	-0.09	-0.37	0.44	-0.22
Net Debt / FCF Ratio	-0.93	-0.93	-1.43	5.53	1.90	-0.19
Asset Turnover	1.70	1.70	1.62	1.16	1.79	1.84
Inventory Turnover	12.01	12.01	11.26	7.53	22.88	8.96
Quick Ratio	1.14	1.14	1.11	0.99	0.97	0.44
Current Ratio	1.98	1.98	1.82	1.51	1.39	0.84
Return on Equity (ROE)	13.78%	13.78%	16.79%	24.98%	66.14%	71.37%
Return on Assets (ROA)	7.49%	7.49%	7.15%	9.46%	26.40%	19.63%
Return on Invested Capital (ROIC)	12.31%	14.28%	16.06%	23.77%	53.60%	77.53%
Return on Capital Employed (ROCE)	14.10%	14.10%	14.10%	14.50%	40.30%	63.30%
Earnings Yield	4.17%	5.05%	2.20%	2.02%	-	-
FCF Yield	0.40%	0.49%	0.23%	-0.19%	-	-
Dividend Yield	0.13%	-	0.07%	0.09%	-	-
Payout Ratio	3.19%	3.19%	4.06%	2.88%	-	-
Buyback Yield / Dilution	19.90%	19.90%	-4.28%	-38.35%	-2.10%	-
Total Shareholder Return	20.03%	19.90%	-4.21%	-38.27%	-2.10%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.